Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers. 2001

X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.

BACKGROUND Fulminant hepatitis in mice could be induced by gene-transfection of Fas ligand (FasL). However, the mechanisms of this event still remain controversial as to whether it is mediated by direct Fas/FasL interaction and/or neutrophil migration. To investigate the role of exogenous FasL-expression, we established a simple but clear mouse model on which we performed liver transplantation between Fas-mutant mice (MRL-lpr/lpr) and wild-type mice (MRL+/+). METHODS The controls were nontransplanted wild-type (group 1) and MRL-lpr/lpr (group 2) mice. We obtained recipients with a Fas defect only in the liver (group 3; MRL-lpr/lpr liver graft in wild-type mice) and Fas-defected recipients with Fas-positive livers (group 4; wild-type graft in MRL-lpr/lpr). We successfully expressed FasL in the liver by cotransfection of two types of adenoviral vectors, AxCALNFasL and AxCANCre, with a Cre-loxP switching system. RESULTS FasL-expression in the livers in groups 3 and 4 resulted in animal death due to fulminant hepatitis within 48 hr after administration of the vectors. We obtained similar findings in group 1, whereas the mice in group 2 survived without any evidence of hepatitis. Immune staining revealed a marked infiltration of CD11b-positive cells in group 1 and group 3. Despite the number of apoptotic cells, a few infiltration of CD11b-positive cells were seen in group 4. We observed no remarkable findings in the FasL-expressed livers in group 2. CONCLUSIONS The results indicated that exogenous FasL-expression induces hepatocyte apoptosis both by direct interaction with Fas and by recruiting Fas-positive inflammatory cells. These findings are important for generating a new strategy to prevent hepatitis as well as for understanding the role of the Fas/FasL interaction in the pathophysiology of hepatitis.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
January 2001, European cytokine network,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
November 1995, Journal of immunology (Baltimore, Md. : 1950),
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
January 1998, Autoimmunity,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
September 2009, Journal of autoimmunity,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
January 1986, Annals of the New York Academy of Sciences,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
November 2005, Journal of leukocyte biology,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
November 1998, Zygote (Cambridge, England),
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
November 1990, Pharmacology, biochemistry, and behavior,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
June 2000, European journal of immunology,
X K Li, and M Fujino, and A Sugioka, and M Morita, and T Okuyama, and L Guo, and N Funeshima, and H Kimura, and S Enosawa, and H Amemiya, and S Suzuki
January 2018, Lupus,
Copied contents to your clipboard!